Gamma vinyl-GABA differentially modulates NMDA antagonist-induced increases in mesocortical versus mesolimbic DA transmission

Neuropsychopharmacology

Volumn 25, Issue 5, 2001, Pages 704-712

  Schiffer, Wynne K ^a,b   Gerasimov, Madina ^a   Hofmann, Lauren ^a   Marsteller, Douglas ^a   Ashby, Charles R ^a   Brodie, Jonathan D ^b   Alexoff, David L ^a   Dewey, Stephen L ^a,b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; GABA; Glutamate; Microdialysis; NMDA antagonist; Phencyclidine; Vigabatrin

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; VIGABATRIN;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; GABAERGIC SYSTEM; LIMBIC CORTEX; MALE; MESENCEPHALON; MICRODIALYSIS; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICONVULSANTS; CEREBRAL CORTEX; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; LIMBIC SYSTEM; MALE; NUCLEUS ACCUMBENS; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOTAXIC TECHNIQUES; SYNAPTIC TRANSMISSION; VIGABATRIN;

EID: 0034778884     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00268-8     Document Type: Article

References (67)

1. Tactile stimulation activates dopamine release in the lateral septum
2. The phenomenology of experimentally induced amphetamine psychosis - Preliminary observations
3. Gamma-vinyl GABA (vigabatrin): Relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children
4. GABA-labeled terminals form proportionally more synapses with dopaminergic neurons containing low densities of tyrosine hydroxylase-immunoreactivity in rat ventral tegmental area
5. A type of aspiny neuron in the rat neostriatum accumulates 3H-gamma-hydroxybutyric acid: Combination of Golgi-staining, autoradiography, and electron microscopy
6. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area
7. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats
8. On the use of multiple probe insertions at the same site for repeated intracerebral microdialysis experiments in the nigrostriatal dopamine system of rats
9. GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex
10. Callosal terminals in the rat prefrontal cortex: Synaptic targets and association with GABA-immunoreactive structures
11. Projections from the rat prefrontal cortex to the ventral tegmental area: Target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons
12. Correlates of patterns of substance abuse among patients with schizophrenia
13. Changes in serotonin2A and GABA(A) receptors in schizophrenia: Studies on the human dorsolateral prefrontal cortex
14. Patterns of substance abuse in schizophrenia: Nature and significance
15. A pharmacologic strategy for the treatment of nicotine addiction
16. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity
17. A novel strategy for the treatment of cocaine addiction
18. The role of afferents to the ventral tegmental area in the handling stress-induced increase in the release of dopamine in the medial prefrontal cortex: A dual-probe microdialysis study in the rat brain
19. The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease
20. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system
21. Tissue and microdialysate changes after repeated and permanent probe implantation in the striatum of freely moving rats
22. Gamma-vinyl gamma-aminobutyric acid attenuates the synergistic elevations of nucleus accumbens dopamine produced by a cocaine/heroin (speedball) challenge
23. Gamma-aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine
24. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
25. The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
26. Recent advances in the phencyclidine model of schizophrenia
27. Gamma-vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: Effects on brain GABA metabolism in mice
28. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists
29. Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum
30. Comparison of effects of hypotension and handling stress on the release of noradrenaline and dopamine in the locus coeruleus and medial prefrontal cortex of the rat
31. GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses
32. Circuits, drugs, and drug addiction
33. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
34. The medial prefrontal cortex plays an important role in the excitation of A10 dopaminergic neurons following intravenous muscimol administration
35. Inhibitory effects of mesocortical dopaminergic neurons on their target cells: Electrophysiological and pharmacological characterization
36. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens
37. Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex
38. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
39. Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine
40. Efferent connections and nigral afferents of the nucleus accumbens septi in the rat
41. GABA(A) and GABA(B) antagonists differentially affect the firing pattern of substantia nigra dopaminergic neurons in vivo
42. Effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl GABA and ethanolamine O-sulphate on the in vitro GABA release from rat hippocampus
43. Antagonism of phencyclidine-induced hyperactivity in mice by elevated brain GABA concentrations
44. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: A microdialysis and behavioral study
45. Interactions between catecholamines and serotonin: Relevance to the pharmacology of schizophrenia
46. Drug dependence study on vigabatrin in rhesus monkeys and rats
47. Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex
48. Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area
49. Dopamine function in the prefrontal cortex
50. Do non-dopaminergic neurons in the ventral tegmental area play a role in the responses elicited in A10 dopaminergic neurons by electrical stimulation of the prefrontal cortex?
51. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration
52. Effects of increasing doses of vigabatrin on platelet gamma-aminobutyric acid-transaminase and brain gamma-aminobutyric acid in rats
53. Neurochemical changes following kainic acid lesions of the nucleus accumbens: Implication for a GABAergic accumbotegmental pathway
54. Biochemical evidence for gamma-aminobutyrate-containing fibers from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat
55. The frontal lobes and schizophrenia
56. The pharmacology of mesocortical dopamine neurons: A dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain
57. The pharmacology of mesolimbic dopamine neurons: A dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain
58. The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK-801
59. Acute d-amphetamine challenge in schizophrenia: Effects on cerebral glucose utilization and clinical symptomatology
60. Presynaptic inhibition preferentially reduces in NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons
61. Nucleus accumbens dopamine release modulation by mesolimbic GABA(A) receptors - An in vivo electrochemical study
62. Increased mesolimbic GABA concentration blocks heroin self-administration in the rat
63. Intra-striatal phencyclidine inhibits N-methyl-D-aspartic acid-stimulated increase in glutamate levels of freely moving rats
64. Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex
65. Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex